Gene · 4091
Papers2,156
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
481 to 500 of 2,156
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Investigation of the Antiremodeling Effects of Losartan, Mirabegron and Their Combination on the Development of Doxorubicin-Induced Chronic Cardiotoxicity in a Rat Model. | Int J Mol Sci | 2022 | 35216317 | PubTator, text mining | PubMed |
| The Role of SMAD4 Inactivation in Epithelial-Mesenchymal Plasticity of Pancreatic Ductal Adenocarcinoma: The Missing Link? | Cancers (Basel) | 2022 | 35205719 | PubTator, text mining | PubMed |
| The Bright and the Dark Side of TGF-β Signaling in Hepatocellular Carcinoma: Mechanisms, Dysregulation, and Therapeutic Implications. | Cancers (Basel) | 2022 | 35205692 | PubTator, text mining | PubMed |
| Insights into the Role of Gremlin-1, a Bone Morphogenic Protein Antagonist, in Cancer Initiation and Progression. | Biomedicines | 2022 | 35203511 | PubTator, text mining | PubMed |
| The Emerging Roles of Pellino Family in Pattern Recognition Receptor Signaling. | Front Immunol | 2022 | 35197966 | PubTator, text mining | PubMed |
| SEC23B Loss-of-Function Suppresses Hepcidin Expression by Impairing Glycosylation Pathway in Human Hepatic Cells. | Int J Mol Sci | 2022 | 35163229 | PubTator, text mining | PubMed |
| Shifting the Focus of Signaling Abnormalities in Colon Cancer. | Cancers (Basel) | 2022 | 35159051 | PubTator, text mining | PubMed |
| Multiple roles of mothers against decapentaplegic homolog 4 in tumorigenesis, stem cells, drug resistance, and cancer therapy. | World J Stem Cells | 2022 | 35126827 | PubTator, text mining | PubMed |
| Simvastatin inhibits stem cell proliferation in human leiomyoma via TGF-β3 and Wnt/β-Catenin pathways. | J Cell Mol Med | 2022 | 35118811 | PubTator, text mining | PubMed |
| The tyrosine kinase inhibitor LPM4870108 impairs learning and memory and induces transcriptomic and gene‑specific DNA methylation changes in rats. | Arch Toxicol | 2022 | 35098321 | PubTator, text mining | PubMed |
| The miR-23b/27b/24-1 Cluster Inhibits Hepatic Fibrosis by Inactivating Hepatic Stellate Cells. | Cell Mol Gastroenterol Hepatol | 2022 | 35093591 | PubTator, text mining | PubMed |
| Uncovering serum placental-related non-coding RNAs as possible biomarkers of preeclampsia risk, onset and severity revealed MALAT-1, miR-363 and miR-17. | Sci Rep | 2022 | 35075166 | PubTator, text mining | PubMed |
| A farewell to phlebotomy-use of placenta-derived drugs Laennec and Porcine for improving hereditary hemochromatosis without phlebotomy: a case report. | J Med Case Rep | 2022 | 35065677 | PubTator, text mining | PubMed |
| Orofacial Cleft and Mandibular Prognathism-Human Genetics and Animal Models. | Int J Mol Sci | 2022 | 35055138 | PubTator, text mining | PubMed |
| Analysis of 5-Azacytidine Resistance Models Reveals a Set of Targetable Pathways. | Cells | 2022 | 35053339 | PubTator, text mining | PubMed |
| The versatility and paradox of BMP signaling in endothelial cell behaviors and blood vessel function. | Cell Mol Life Sci | 2022 | 35044529 | PubTator, text mining | PubMed |
| The genetics of glaucoma: Disease associations, personalised risk assessment and therapeutic opportunities-A review. | Clin Exp Ophthalmol | 2022 | 35037362 | PubTator, text mining | PubMed |
| Protein disulfide isomerase A1‑associated pathways in the development of stratified breast cancer therapies. | Int J Oncol | 2022 | 35014681 | PubTator, text mining | PubMed |
| Biological and molecular profile of fracture non-union tissue: A systematic review and an update on current insights. | J Cell Mol Med | 2022 | 34984803 | PubTator, text mining | PubMed |
| Comprehensive analysis of the long noncoding RNA-associated competitive endogenous RNA network in the osteogenic differentiation of periodontal ligament stem cells. | BMC Genomics | 2022 | 34979896 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4091/papers?page=25